glp-1 telehealth crackdown news today Copycat Weight-Loss Pill Removed From the Market Amid FDA The FDA announced plans to

Kamiya, M

Medical understanding consistently flags this risk for anyone using these injections at high doses over extended periods without regular health monitoring

Long-term studies on high-dose IV use are still limited, but no serious adverse effects have been documented in short-term studies

Current Available Once Weekly Injectable GLP-1 Medications : Tirzepatide (GLP-1 and GIP agonist) Semaglutide Liraglutide Dulaglutide Current Available Daily Oral GLP-1 Medications: Semaglutide Orforglipron Of note, there are other GLP-1 medication combinations in the research pipeline, including a once a month injection, and oral medications that combine the GLP-1s with other beneficial compounds